Contingency Management for the Treatment of Stimulant Use Disorder
JAMA Internal Medicine · 01.07.2026 · 186 (7) · 892
DOI: 10.1001/jamainternmed.2026.1163 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Internal Medicine, erschienen am 01.07.2026. Verfasst von Amy J Kennedy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Internal Medicine, University of Washington School of Medicine, VA Puget Sound Health Care System, Seattle. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
This Clinical Insights discusses the use of contingency management for the treatment of stimulant use disorder.
Autor:innen und Institutionen
- Division of General Internal Medicine, University of Washington School of Medicine, VA Puget Sound Health Care System, Seattle.
- University of Washington School of Medicine, Harborview Medical Center, Seattle.
- Oregon Health and Science University, Portland.
Zitieren
APA
Kennedy, A. J., Bhatraju, E. P., & Chan, B. (2026). Contingency Management for the Treatment of Stimulant Use Disorder. JAMA Internal Medicine, 186(7), 892. https://doi.org/10.1001/jamainternmed.2026.1163
Vancouver
Kennedy AJ, Bhatraju EP, Chan B. Contingency Management for the Treatment of Stimulant Use Disorder. JAMA Internal Medicine. 2026;186(7):892. doi:10.1001/jamainternmed.2026.1163
BibTeX
@article{Kennedy2026,
author = {Kennedy, Amy J and Bhatraju, Elenore P and Chan, Brian},
title = {Contingency Management for the Treatment of Stimulant Use Disorder},
journal = {JAMA Internal Medicine},
year = {2026},
volume = {186},
number = {7},
pages = {892},
doi = {10.1001/jamainternmed.2026.1163}
}
EUVIMED